Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
The oral bioavailability of ABT-888 dihydrochloride is 56%-92% in mice
PubMed Central PMCID: PMC2797793
Chemical Name: 2-phenylpropane-1
Epub 2011 Sep 28
and safe mGlu5 inhibitor with good oral bioavailability and long half-life supportive of once-daily administration
TraMetinib - CAS# 871700-17-3 0201 The oral bioavailability of ABT-888Trametinib, also known as GSK1120212, CAS No. 871700 17 3, is a n orally bioavailable inhibitor of mitogen activated protein kinase kinase (MEK MAPK ERK kinase) with potential antineoplastic activity. Trametinib specifically binds to and inhibits MEK 1 and 2, resulting in an inhibition of growth factor mediated cell signaling and cellular proliferation in various cancers. MEK 1 and 2, dual specificity threonine tyrosine kinases often upregulated in
US$ 35.00
US$ 10.00
US$ 10.00
US$ 21.00
US$ 12.50